In the past week, ICU stock has gone up by 26.81%, with a monthly decline of -61.68% and a quarterly plunge of -72.53%. The volatility ratio for the week is 29.31%, and the volatility levels for the last 30 days are 20.02% for SeaStar Medical Holding Corp The simple moving average for the last 20 days is -47.02% for ICU stock, with a simple moving average of -78.72% for the last 200 days.
Is It Worth Investing in SeaStar Medical Holding Corp (NASDAQ: ICU) Right Now?
The price-to-earnings ratio for SeaStar Medical Holding Corp (NASDAQ: ICU) is N/Ax, which is above its average ratio. Moreover, the 36-month beta value for ICU is -1.07. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The average price recommended by analysts for SeaStar Medical Holding Corp (ICU) is N/A, which is -$5199993.0 below the current market price. The public float for ICU is 15.64M and currently, short sellers hold a 0.51% of that float. On July 01, 2025, ICU’s average trading volume was 5.20M shares.
ICU) stock’s latest price update
SeaStar Medical Holding Corp (NASDAQ: ICU) has seen a rise in its stock price by 7.12 in relation to its previous close of 0.43. However, the company has experienced a 26.81% gain in its stock price over the last five trading sessions. globenewswire.com reported 2025-06-25 that DENVER, June 25, 2025 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU) a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today that it has undertaken a series of transactions to ensure compliance with Nasdaq’s continued listing standards.
Analysts’ Opinion of ICU
Many brokerage firms have already submitted their reports for ICU stocks, with N/A repeating the rating for ICU by listing it as a “N/A.” The predicted price for ICU in the upcoming period, according to N/A is N/A based on the research report published on N/A of the N/A year N/A.
N/A, on the other hand, stated in their research note that they expect to see ICU reach a price target of N/A. The rating they have provided for ICU stocks is “N/A” according to the report published on N/A.
N/A gave a rating of “N/A” to ICU, setting the target price at N/A in the report published on N/A of the N/A year.
ICU Trading at -58.35% from the 50-Day Moving Average
After a stumble in the market that brought ICU to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -96.71% of loss for the given period.
Volatility was left at 20.02%, however, over the last 30 days, the volatility rate increased by 29.31%, as shares sank -61.43% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -63.59% lower at present.
During the last 5 trading sessions, ICU rose by +26.56%, which changed the moving average for the period of 200-days by -91.23% in comparison to the 20-day moving average, which settled at $0.8606. In addition, SeaStar Medical Holding Corp saw -93.38% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ICU starting from Neuman John, who purchase 40,000 shares at the price of $0.36 back on Jun 24 ’25. After this action, Neuman John now owns 80,000 shares of SeaStar Medical Holding Corp, valued at $14,396 using the latest closing price.
Baird Jennifer A, the Director of SeaStar Medical Holding Corp, purchase 10,000 shares at $1.28 during a trade that took place back on May 20 ’25, which means that Baird Jennifer A is holding 10,000 shares at $12,815 based on the most recent closing price.
Stock Fundamentals for ICU
Current profitability levels for the company are sitting at:
- -41.39 for the present operating margin
- 1.0 for the gross margin
The net margin for SeaStar Medical Holding Corp stands at -37.16. The total capital return value is set at -31.35. Equity return is now at value N/A, with -207.41 for asset returns.
Based on SeaStar Medical Holding Corp (ICU), the company’s capital structure generated 0.39 points at debt to capital in total, while cash flow to debt ratio is standing at -41.8. The debt to equity ratio resting at 0.64. The interest coverage ratio of the stock is -196.82.
Currently, EBITDA for the company is -24.58 million with net debt to EBITDA at 0.31. When we switch over and look at the enterprise to sales, we see a ratio of 5.81. The receivables turnover for the company is 3.89for trailing twelve months and the total asset turnover is 0.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.96.
Conclusion
To wrap up, the performance of SeaStar Medical Holding Corp (ICU) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
